This study expands our understanding of the hematopoietic activities of the CD137/CD137L system by demonstrating that reverse CD137L signaling initiated by CD137+, activated CD4+ T cells in hematopoietic progenitor cells not only drives myelopoiesis during infections but also in aging. Here, TNFRSF9 is linked to infection.